Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
Dow
Johnson and Johnson
McKinsey
Colorcon

Last Updated: May 24, 2022

ETHINYL ESTRADIOL AND NORELGESTROMIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

When do Ethinyl Estradiol And Norelgestromin patents expire, and when can generic versions of Ethinyl Estradiol And Norelgestromin launch?

Ethinyl Estradiol And Norelgestromin is a drug marketed by Amneal and is included in one NDA.

The generic ingredient in ETHINYL ESTRADIOL AND NORELGESTROMIN is ethinyl estradiol; norelgestromin. There are twenty-six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norelgestromin profile page.

Summary for ETHINYL ESTRADIOL AND NORELGESTROMIN
Drug patent expirations by year for ETHINYL ESTRADIOL AND NORELGESTROMIN
Recent Clinical Trials for ETHINYL ESTRADIOL AND NORELGESTROMIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Mylan Technologies Inc.Phase 3
Mylan Inc.Phase 3
Janssen Research & Development, LLCPhase 4

See all ETHINYL ESTRADIOL AND NORELGESTROMIN clinical trials

US Patents and Regulatory Information for ETHINYL ESTRADIOL AND NORELGESTROMIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal ETHINYL ESTRADIOL AND NORELGESTROMIN ethinyl estradiol; norelgestromin FILM, EXTENDED RELEASE;TRANSDERMAL 213950-001 Feb 25, 2021 BX RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
AstraZeneca
McKinsey
Harvard Business School
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.